Recurrent Urinary Tract Infection in Women: Bridging Antibiotic Resistance, Non-Antibiotic Prevention, and Practical Management

Purpose: Recurrent urinary tract infection in women causes significant morbidity, and antimicrobial resistance is rising. This review asks how strong the evidence is for antibiotic and non-antibiotic prevention, how Saudi resistance data should shape the choice of agent, and how to build a stepwise plan. Methods: PubMed search, November 2026; practical statements labeled by source type. Results: Antibiotic prophylaxis reduces recurrences while taken, but no benefit after it stops has been shown; it also adds adverse effects and selection pressure. Methenamine hippurate met the non-inferiority margin against daily antibiotics in one open-label trial, although antibiotic-treated infections were more frequent; a placebo-controlled trial in older women found a borderline benefit during treatment and more antibiotic treatments after it stopped. A placebo-controlled primary care trial of D-mannose showed no reduction in suspected infection; cranberry probably reduced infection in women with recurrent infection, with an interval that only just excludes no effect; vaginal estrogen, a sublingual bacterial vaccine and increased water intake have supporting randomized trials, among them one in thirty-five women and others that were industry-funded or open-label. Saudi hospital studies report extended-spectrum beta-lactamase production in about one third of Escherichia coli isolates in Riyadh and more than half resistant to fluoroquinolones and trimethoprim-sulfamethoxazole in Madinah, but none is limited to women with recurrent infection. Conclusion: In the authors' opinion, a culture-confirmed diagnosis, no treatment of asymptomatic bacteriuria and non-antibiotic measures come first, then antibiotic prophylaxis if these fail, with the agent chosen by culture and antibiogram.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-22
DOI
https://doi.org/10.5281/zenodo.24430881
Primary Topic
Urinary Tract Infections Management
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Recurrent Urinary Tract Infection in Women: Bridging Antibiotic Resistance, Non-Antibiotic Prevention, and Practical Management

Salman Mashary Alharbi, Mohammed Ibrahim Abu Hulayyil
Zenodo (CERN European Organization for Nuclear Research)
Urinary Tract Infections Management
preprint

Recurrent Urinary Tract Infection in Women: Bridging Antibiotic Resistance, Non-Antibiotic Prevention, and Practical Management

Salman Mashary Alharbi, Mohammed Ibrahim Abu Hulayyil
preprint en

Abstract

Purpose: Recurrent urinary tract infection in women causes significant morbidity, and antimicrobial resistance is rising. This review asks how strong the evidence is for antibiotic and non-antibiotic prevention, how Saudi resistance data should shape the choice of agent, and how to build a stepwise plan. Methods: PubMed search, November 2026; practical statements labeled by source type. Results: Antibiotic prophylaxis reduces recurrences while taken, but no benefit after it stops has been shown; it also adds adverse effects and selection pressure. Methenamine hippurate met the non-inferiority margin against daily antibiotics in one open-label trial, although antibiotic-treated infections were more frequent; a placebo-controlled trial in older women found a borderline benefit during treatment and more antibiotic treatments after it stopped. A placebo-controlled primary care trial of D-mannose showed no reduction in suspected infection; cranberry probably reduced infection in women with recurrent infection, with an interval that only just excludes no effect; vaginal estrogen, a sublingual bacterial vaccine and increased water intake have supporting randomized trials, among them one in thirty-five women and others that were industry-funded or open-label. Saudi hospital studies report extended-spectrum beta-lactamase production in about one third of Escherichia coli isolates in Riyadh and more than half resistant to fluoroquinolones and trimethoprim-sulfamethoxazole in Madinah, but none is limited to women with recurrent infection. Conclusion: In the authors' opinion, a culture-confirmed diagnosis, no treatment of asymptomatic bacteriuria and non-antibiotic measures come first, then antibiotic prophylaxis if these fail, with the agent chosen by culture and antibiogram.

Zenodo (CERN European Organization for Nuclear Research)
King Saud University (SA)
Urinary Tract Infections Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Recurrent Urinary Tract Infection in Women: Bridging Antibiotic Resistance, Non-Antibiotic Prevention, and Practical Management — Salman Mashary Alharbi, Mohammed Ibrahim Abu Hulayyil · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS